Surgical outcomes of primary prolene intraluminal ripcord use in Preserflo MicroShunt surgery in patients at high risk for hypotony

Background/aims To assess real-world outcomes of Preserflo MicroShunt (PMS) implantation combined with primary intraluminal ripcord (stent) insertion using a 9–0 polypropylene suture. Methods A consecutive retrospective cohort study including all adult patients undergoing PMS implantation with primary intraluminal stenting at a single centre between September 2021 and May 2024. Participants were followed for a minimum of 6 months and up to 18 months postoperatively. Results Thirty-eight eyes of 35 patients were analysed. The overall surgical success rate at 6 months was 89.5% (complete success 81.6%; qualified success 7.9%). Mean intraocular pressure (IOP) decreased significantly from baseline at all visits, with mean percentage reductions of 40.1%, 34.1% and 30% at 6, 12 and 18 months, respectively (all p<0.001). Glaucoma medication use also decreased significantly at all timepoints (all p<0.001), averaging 0.12±0.48 medications at 6 months. Intraluminal stents were removed in 63.2% of eyes at a median of 84 days post-surgery (IQR 35–124). Numerical hypotony (IOP <6 mm Hg without visual or anatomical sequelae) occurred in six eyes (15.8%), all resolving with conservative management. Conclusions Primary intraluminal stenting with a 9–0 prolene suture effectively prevented clinically significant hypotony while maintaining stable IOP and reduced medication dependence at 6 months. These outcomes remained stable in the subset of patients followed for up to 18 months after PMS implantation.

Authors

Institutions

Publication Details

Journal
British Journal of Ophthalmology
Published
2026-11-16
DOI
https://doi.org/10.1136/bjo-2025-329381
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Surgical outcomes of primary prolene intraluminal ripcord use in Preserflo MicroShunt surgery in patients at high risk for hypotony

Liat Mendel, Chandni Gupta, Kelsey V. Stuart, Muhammad Ali Abouhamid et al.
6 links
British Journal of Ophthalmology
Glaucoma and retinal disorders
article

Surgical outcomes of primary prolene intraluminal ripcord use in Preserflo MicroShunt surgery in patients at high risk for hypotony

Liat Mendel, Chandni Gupta, Kelsey V. Stuart, Muhammad Ali Abouhamid, Keith Barton, Soledad Aguilar Munoa
article en

Abstract

Background/aims To assess real-world outcomes of Preserflo MicroShunt (PMS) implantation combined with primary intraluminal ripcord (stent) insertion using a 9–0 polypropylene suture. Methods A consecutive retrospective cohort study including all adult patients undergoing PMS implantation with primary intraluminal stenting at a single centre between September 2021 and May 2024. Participants were followed for a minimum of 6 months and up to 18 months postoperatively. Results Thirty-eight eyes of 35 patients were analysed. The overall surgical success rate at 6 months was 89.5% (complete success 81.6%; qualified success 7.9%). Mean intraocular pressure (IOP) decreased significantly from baseline at all visits, with mean percentage reductions of 40.1%, 34.1% and 30% at 6, 12 and 18 months, respectively (all p<0.001). Glaucoma medication use also decreased significantly at all timepoints (all p<0.001), averaging 0.12±0.48 medications at 6 months. Intraluminal stents were removed in 63.2% of eyes at a median of 84 days post-surgery (IQR 35–124). Numerical hypotony (IOP <6 mm Hg without visual or anatomical sequelae) occurred in six eyes (15.8%), all resolving with conservative management. Conclusions Primary intraluminal stenting with a 9–0 prolene suture effectively prevented clinically significant hypotony while maintaining stable IOP and reduced medication dependence at 6 months. These outcomes remained stable in the subset of patients followed for up to 18 months after PMS implantation.

British Journal of Ophthalmology
Moorfields Eye Hospital NHS Foundation Trust (GB), Tel Aviv University (IL), Tanta University (EG), Wolfson Medical Center (IL), Moorfields Eye Hospital (GB), University College London (GB)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon